Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",3.9289172680485053e-07,7.846372688477952,115.7318925017012,"['GPR27', 'HRH1', 'MC1R', 'GPR12', 'P2RY14', 'CHRM5', 'OPRK1', 'ADRA1D', 'NMBR', 'HTR5A', 'MCHR1', 'HCRTR2']",0.00013122583675282009,0,0,12
2,Peptide GPCRs WP24,0.00014110559116487414,13.625277161862527,120.80173558056075,"['MC1R', 'OPRK1', 'NMBR', 'ACKR1', 'HCRTR2']",0.019945438531371106,0,0,5
3,Cholesterol Biosynthesis Pathway WP197,0.0002048113608112795,12.261640798226164,104.14327982428516,"['SQLE', 'NSDHL', 'HMGCS1', 'MSMO1', 'FDFT1']",0.019945438531371106,0,0,5
4,ACE Inhibitor Pathway WP554,0.00023886752732180967,73.30463576158941,611.3314458600262,"['TGFB1', 'ATP6AP2', 'AGT']",0.019945438531371106,0,0,3
5,Vitamin D Receptor Pathway WP2877,0.0005384639657768126,4.350177654954599,32.74287358247584,"['ADAMTS5', 'ABCB1', 'TGFB1', 'IGFBP5', 'GADD45A', 'CDKN2A', 'PNOC', 'TIMP2', 'TIMP3']",0.03596939291389108,0,0,9
6,Photodynamic therapy-induced unfolded protein response WP3613,0.0014280339049236427,7.208164862397287,47.22397978353267,"['XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'BBC3']",0.05796315282768926,0,0,5
7,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.0015618813636203693,inf,inf,"['TGFB1', 'VIP']",0.05796315282768926,0,0,2
8,COVID-19 adverse outcome pathway WP4891,0.0015618813636203693,inf,inf,"['IL7', 'AGT']",0.05796315282768926,0,0,2
9,Gastric acid production WP2596,0.0015618813636203693,inf,inf,"['CCK', 'VIP']",0.05796315282768926,0,0,2
10,Allograft Rejection WP2328,0.00215938883144777,6.448243669039561,39.57886855836893,"['ABCB1', 'TGFB1', 'HLA-C', 'HLA-A', 'HLA-F']",0.07212358697035551,0,0,5
11,Monoamine GPCRs WP58,0.003816176307007735,7.526889040163376,41.91352922333722,"['HRH1', 'CHRM5', 'ADRA1D', 'HTR5A']",0.11587298968550759,0,0,4
12,Unfolded protein response WP4925,0.005837797122544718,6.522123893805309,33.545903503544984,"['XBP1', 'HSPA5', 'DDIT3', 'BBC3']",0.1624853532441613,0,0,4
13,TP53 network WP1742,0.008004618341096585,9.157284768211921,44.20895893499691,"['CDKN2A', 'GADD45A', 'BBC3']",0.20565711737894304,0,0,3
14,Cytokines and Inflammatory Response WP530,0.008886365400000172,24.378854625550662,115.1471119503254,"['TGFB1', 'IL7']",0.21200328882857553,0,0,2
15,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.010363203111450942,8.139072847682119,37.19144380479422,"['TGFB1', 'FN1', 'IGFBP7']",0.21633186495153842,0,0,3
16,Statin inhibition of cholesterol production WP430,0.010363203111450942,8.139072847682119,37.19144380479422,"['SQLE', 'LDLR', 'FDFT1']",0.21633186495153842,0,0,3
17,Dopaminergic Neurogenesis WP2855,0.014424230351709788,16.251101321585903,68.88591295906059,"['TGFB1', 'ASCL1']",0.26764960763728163,0,0,2
18,NAD Biosynthesis II (from tryptophan) WP2485,0.014424230351709788,16.251101321585903,68.88591295906059,"['NMNAT1', 'KMO']",0.26764960763728163,0,0,2
19,Imatinib and Chronic Myeloid Leukemia WP3640,0.016169026700456536,6.658037326911499,27.462125585743106,"['SPRED2', 'ABCB1', 'GADD45A']",0.2842344693659201,0,0,3
20,Development of ureteric collection system WP5053,0.018112958501363588,4.4440868865647625,17.825799823347566,"['FRAS1', 'ETV4', 'GLI3', 'FREM2']",0.3024864069727719,0,0,4
21,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.02418577376583276,3.3058668424522084,12.304405575584227,"['SQLE', 'NSDHL', 'HMGCS1', 'MSMO1', 'FDFT1']",0.3512194972951366,0,0,5
22,Endochondral Ossification with Skeletal Dysplasias WP4808,0.02418577376583276,3.3058668424522084,12.304405575584227,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'GLI3']",0.3512194972951366,0,0,5
23,Endochondral Ossification WP474,0.02418577376583276,3.3058668424522084,12.304405575584227,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'GLI3']",0.3512194972951366,0,0,5
24,Sleep regulation WP3591,0.027673607531314783,5.2298959318826865,18.761080769225266,"['AHCY', 'CRH', 'HCRTR2']",0.3839502412632961,0,0,3
25,Mevalonate pathway WP3963,0.02873879051371977,9.748898678414097,34.60378880948034,"['HMGCS1', 'ACAT2']",0.3839502412632961,0,0,2
26,Matrix Metalloproteinases WP129,0.03732884890113771,8.123348017621145,26.709477481505967,"['TIMP2', 'TIMP3']",0.44046284451839673,0,0,2
27,miR-509-3p alteration of YAP1/ECM axis WP3967,0.03732884890113771,8.123348017621145,26.709477481505967,"['PBX3', 'FN1']",0.44046284451839673,0,0,2
28,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.039562530944766174,inf,inf,['FMO5'],0.44046284451839673,0,0,1
29,Codeine and Morphine Metabolism WP1604,0.039562530944766174,inf,inf,['ABCB1'],0.44046284451839673,0,0,1
30,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.039562530944766174,inf,inf,['AGT'],0.44046284451839673,0,0,1
31,Cardiac Progenitor Differentiation WP2406,0.04252945299593186,4.3058044409816905,13.5958291166006,"['TGFB1', 'TNNT2', 'THY1']",0.4439011656450388,0,0,3
32,Genes controlling nephrogenesis WP4823,0.04252945299593186,4.3058044409816905,13.5958291166006,"['CD36', 'ETV4', 'GLI3']",0.4439011656450388,0,0,3
33,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.046759102275643755,6.962240402769037,21.323576319550494,"['SST', 'DCN']",0.4462154331447147,0,0,2
34,Development and heterogeneity of the ILC family WP3893,0.046759102275643755,6.962240402769037,21.323576319550494,"['NFIL3', 'IL7']",0.4462154331447147,0,0,2
35,Major receptors targeted by epinephrine and norepinephrine WP4589,0.046759102275643755,6.962240402769037,21.323576319550494,"['ADCY10', 'ADRA1D']",0.4462154331447147,0,0,2
36,IL-6 signaling pathway WP364,0.05251325558704552,3.0525442477876106,8.994900552972261,"['PRKCD', 'GAB1', 'VIP', 'AGT']",0.48720631572425566,0,0,4
37,Senescence and Autophagy in Cancer WP615,0.05483665477768804,2.3295238095238093,6.76353110244809,"['TGFB1', 'IGFBP5', 'CDKN2A', 'FN1', 'IGFBP7', 'CXCL14']",0.4891435792607659,0,0,6
38,Kynurenine Pathway and links to Cellular Senescence WP5044,0.05694993307474064,6.091409691629956,17.455438622307014,"['KMO', 'ACMSD']",0.4891435792607659,0,0,2
39,Selenium Micronutrient Network WP15,0.057115567638233146,2.9597747385358004,8.472883690377005,"['PNPO', 'KMO', 'SEPHS2', 'LDLR']",0.4891435792607659,0,0,4
40,Myometrial relaxation and contraction pathways WP289,0.06419413599355193,1.9589285714285714,5.378911112675179,"['PRKCH', 'IGFBP5', 'RGS16', 'PRKCD', 'CRH', 'ATF5', 'CORIN', 'ACTG1']",0.5294412112710163,0,0,8
41,G1 to S cell cycle control WP45,0.06694515728899093,2.7901390644753477,7.544205518028926,"['CDKN2A', 'GADD45A', 'RPA3', 'POLE2']",0.5294412112710163,0,0,4
42,Tryptophan catabolism leading to NAD+ production WP4210,0.06782668464025263,5.41409691629956,14.568249723091398,"['NMNAT1', 'KMO']",0.5294412112710163,0,0,2
43,Adipogenesis WP236,0.06845398323525906,2.1896517412935323,5.871755957832253,"['SFRP4', 'TGFB1', 'GADD45A', 'DDIT3', 'NDN', 'AGT']",0.5294412112710163,0,0,6
44,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.06974674639498418,2.3953306377983568,6.378488842225484,"['TGFB1', 'GADD45A', 'TCF7', 'BBC3', 'GADD45G']",0.5294412112710163,0,0,5
45,Bladder cancer WP2828,0.07432536093398236,3.325707405177604,8.644521414826407,"['RPS6KA5', 'CDKN2A', 'DAPK2']",0.5298535563458097,0,0,3
46,Composition of Lipid Particles WP3601,0.07756327126359693,24.327472527472526,62.19710686387212,['LDLR'],0.5298535563458097,0,0,1
47,Drug Induction of Bile Acid Pathway WP2289,0.07756327126359693,24.327472527472526,62.19710686387212,['ABCB1'],0.5298535563458097,0,0,1
48,EV release from cardiac cells and their functional effects WP3297,0.07756327126359693,24.327472527472526,62.19710686387212,['RGS16'],0.5298535563458097,0,0,1
49,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.07931939466254637,4.872246696035242,12.347601336046825,"['TGFB1', 'FN1']",0.5298535563458097,0,0,2
50,miRNA targets in ECM and membrane receptors WP2911,0.07931939466254637,4.872246696035242,12.347601336046825,"['COL5A2', 'FN1']",0.5298535563458097,0,0,2
51,Tumor suppressor activity of SMARCB1 WP4204,0.09720355408927353,2.9258278145695362,6.819952502896398,"['CDKN2A', 'ACTL6A', 'GLI3']",0.617446704633042,0,0,3
52,DNA Replication WP466,0.09720355408927353,2.9258278145695362,6.819952502896398,"['RPA3', 'POLE2', 'GMNN']",0.617446704633042,0,0,3
53,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.09797806989685996,2.142023573345781,4.9759456124596655,"['SQLE', 'HMGCS1', 'INSIG1', 'LDLR', 'FDFT1']",0.617446704633042,0,0,5
54,Tgif disruption of Shh signaling WP3674,0.11406365815191445,12.162637362637362,26.405068462755324,['GLI3'],0.6295298658844626,0,0,1
55,Vitamin B6-dependent and responsive disorders WP4228,0.11406365815191445,12.162637362637362,26.405068462755324,['PNPO'],0.6295298658844626,0,0,1
56,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.11406365815191445,12.162637362637362,26.405068462755324,['ABCB1'],0.6295298658844626,0,0,1
57,Platelet-mediated interactions with vascular and circulating cells WP4462,0.11406365815191445,12.162637362637362,26.405068462755324,['TGFB1'],0.6295298658844626,0,0,1
58,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.11685883737975054,3.7468654693324295,8.04372804058228,"['HMGCS1', 'LDLR']",0.6295298658844626,0,0,2
59,Striated Muscle Contraction Pathway WP383,0.11685883737975054,3.7468654693324295,8.04372804058228,"['TNNT2', 'ACTG1']",0.6295298658844626,0,0,2
60,Type II interferon signaling (IFNG) WP619,0.11685883737975054,3.7468654693324295,8.04372804058228,"['PRKCD', 'IFIT2']",0.6295298658844626,0,0,2
61,Gastric Cancer Network 1 WP2361,0.11685883737975054,3.7468654693324295,8.04372804058228,"['ACTL6A', 'GATD3B']",0.6295298658844626,0,0,2
62,One-carbon metabolism WP241,0.11685883737975054,3.7468654693324295,8.04372804058228,"['AHCY', 'CHDH']",0.6295298658844626,0,0,2
63,p38 MAPK Signaling Pathway WP400,0.12253744845935727,2.6116367076631977,5.482709733918976,"['RPS6KA5', 'DDIT3', 'HMGN1']",0.6496429807210369,0,0,3
64,Breast cancer pathway WP4262,0.12993812291557927,1.808888888888889,3.6913939831147022,"['SFRP4', 'SHC3', 'GADD45A', 'TCF7', 'FGF1', 'GADD45G']",0.6588961840505952,0,0,6
65,Methionine De Novo and Salvage Pathway WP3580,0.13020104235730326,3.4789175582127125,7.092384143513998,"['AHCY', 'CHDH']",0.6588961840505952,0,0,2
66,Pre-implantation embryo WP3527,0.13020104235730326,3.4789175582127125,7.092384143513998,"['DLX2', 'DDIT3']",0.6588961840505952,0,0,2
67,Endometrial cancer WP4155,0.1347995674352747,2.1208156983455173,4.250043165612739,"['GADD45A', 'TCF7', 'FGF1', 'GADD45G']",0.6621037576967904,0,0,4
68,Oncostatin M Signaling Pathway WP2374,0.1347995674352747,2.1208156983455173,4.250043165612739,"['PRKCH', 'PRKCD', 'TIMP3', 'LDLR']",0.6621037576967904,0,0,4
69,Pancreatic adenocarcinoma pathway WP4263,0.14312239987191044,1.8770254136107796,3.6490407749881433,"['TGFB1', 'CDKN2A', 'GADD45A', 'PRKCD', 'GADD45G']",0.6730677310043292,0,0,5
70,Differentiation Pathway WP2848,0.14387137497925928,3.246696035242291,6.294809881103081,"['TGFB1', 'FGF1']",0.6730677310043292,0,0,2
71,NAD+ biosynthetic pathways WP3645,0.14387137497925928,3.246696035242291,6.294809881103081,"['NMNAT1', 'ACMSD']",0.6730677310043292,0,0,2
72,Bile acids synthesis and enterohepatic circulation  WP4389,0.14912279070155796,8.107692307692307,15.428818579184162,['LDLR'],0.6730677310043292,0,0,1
73,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.14912279070155796,8.107692307692307,15.428818579184162,['FN1'],0.6730677310043292,0,0,1
74,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.14912279070155796,8.107692307692307,15.428818579184162,['LDLR'],0.6730677310043292,0,0,1
75,White fat cell differentiation WP4149,0.157823141952428,3.0435022026431717,5.619157939494648,"['DDIT3', 'NR2F2']",0.702839058828146,0,0,2
76,Proteasome Degradation WP183,0.16446928943529704,1.9504424778761063,3.520609948776008,"['H2AFZ', 'HLA-C', 'HLA-A', 'HLA-F']",0.7227992456761738,0,0,4
77,Angiogenesis WP1539,0.17201281654992326,2.8642135268204196,5.041549381884526,"['TIMP2', 'TIMP3']",0.7281547508048369,0,0,2
78,DNA Mismatch Repair WP531,0.17201281654992326,2.8642135268204196,5.041549381884526,"['RPA3', 'POLE2']",0.7281547508048369,0,0,2
79,Apoptosis Modulation and Signaling WP1772,0.17222821950174286,1.912024986985945,3.3631273341551458,"['ENDOG', 'CDKN2A', 'PTPN13', 'BBC3']",0.7281547508048369,0,0,4
80,Farnesoid X receptor pathway WP2879,0.18279745393881391,6.08021978021978,10.332582902308358,['FKBP5'],0.7435527872520528,0,0,1
81,Inflammatory Response Pathway WP453,0.18279745393881391,6.08021978021978,10.332582902308358,['FN1'],0.7435527872520528,0,0,1
82,Endothelin Pathways WP2197,0.18639986199341246,2.7048458149779737,4.543765312358149,"['ADCY10', 'MYLK']",0.7435527872520528,0,0,2
83,Folate Metabolism WP176,0.18639986199341246,2.7048458149779737,4.543765312358149,"['AHCY', 'LDLR']",0.7435527872520528,0,0,2
84,DNA damage response (only ATM dependent) WP710,0.1886662337762479,1.6934589800443458,2.824309877983007,"['TGFB1', 'CDKN2A', 'TCF7', 'LDLR', 'BBC3']",0.7435527872520528,0,0,5
85,Retinoblastoma gene in cancer WP2446,0.19622541716239933,1.8053097345132743,2.939931003350568,"['ANLN', 'H2AFZ', 'RPA3', 'POLE2']",0.7435527872520528,0,0,4
86,Lung fibrosis WP3624,0.2009465639182901,2.5622536517505217,4.11169009059918,"['TGFB1', 'FGF1']",0.7435527872520528,0,0,2
87,Exercise-induced Circadian Regulation WP410,0.20968966883609563,1.9747628423125112,3.0848295818228513,"['PER2', 'RBPMS', 'HERPUD1']",0.7435527872520528,0,0,3
88,Selective expression of chemokine receptors during T-cell polarization WP4494,0.21514220264719516,4.863736263736263,7.47291706554417,['TGFB1'],0.7435527872520528,0,0,1
89,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.21514220264719516,4.863736263736263,7.47291706554417,['TCF7'],0.7435527872520528,0,0,1
90,Sulfation Biotransformation Reaction WP692,0.21514220264719516,4.863736263736263,7.47291706554417,['PAPSS2'],0.7435527872520528,0,0,1
91,Biogenic Amine Synthesis WP550,0.21514220264719516,4.863736263736263,7.47291706554417,['GAD1'],0.7435527872520528,0,0,1
92,Transcriptional cascade regulating adipogenesis WP4211,0.21514220264719516,4.863736263736263,7.47291706554417,['DDIT3'],0.7435527872520528,0,0,1
93,"Degradation pathway of sphingolipids, including diseases WP4153",0.21514220264719516,4.863736263736263,7.47291706554417,['NEU1'],0.7435527872520528,0,0,1
94,IL1 and megakaryocytes in obesity WP2865,0.21514220264719516,4.863736263736263,7.47291706554417,['TIMP2'],0.7435527872520528,0,0,1
95,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.21514220264719516,4.863736263736263,7.47291706554417,['AHCY'],0.7435527872520528,0,0,1
96,DNA damage response WP707,0.22011847902821344,1.9226211223422796,2.9100588290100338,"['GADD45A', 'BBC3', 'GADD45G']",0.7435527872520528,0,0,3
97,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.22011847902821344,1.9226211223422796,2.9100588290100338,"['XBP1', 'HSPA5', 'DDIT3']",0.7435527872520528,0,0,3
98,MECP2 and Associated Rett Syndrome WP3584,0.22117042018338015,1.7098276665114114,2.5798251593014307,"['SST', 'GAD1', 'OPRK1', 'FKBP5']",0.7435527872520528,0,0,4
99,Ebola Virus Pathway on Host WP4217,0.22397071759362153,1.582774210268667,2.368210022170684,"['HLA-C', 'HLA-A', 'HLA-F', 'ASGR1', 'ACTG1']",0.7435527872520528,0,0,5
100,Phosphodiesterases in neuronal function WP4222,0.23064966498557757,1.8731533367294957,2.7476449398902942,"['ADCY10', 'PDE5A', 'PDE6B']",0.7435527872520528,0,0,3
101,miRNA regulation of DNA damage response WP1530,0.24127122467814152,1.826158940397351,2.5964940759200448,"['GADD45A', 'BBC3', 'GADD45G']",0.7435527872520528,0,0,3
102,Cancer immunotherapy by PD-1 blockade WP4585,0.24620944730585062,4.052747252747253,5.680219883038032,['HLA-A'],0.7435527872520528,0,0,1
103,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.24620944730585062,4.052747252747253,5.680219883038032,['NSDHL'],0.7435527872520528,0,0,1
104,Dual hijack model of Vif in HIV infection WP3300,0.24620944730585062,4.052747252747253,5.680219883038032,['RUNX1'],0.7435527872520528,0,0,1
105,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.24620944730585062,4.052747252747253,5.680219883038032,['GALNT3'],0.7435527872520528,0,0,1
106,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.24620944730585062,4.052747252747253,5.680219883038032,['TGFB1'],0.7435527872520528,0,0,1
107,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.25197145318859426,1.781456953642384,2.4556305948351036,"['SFRP4', 'TCF7', 'CXXC4']",0.7435527872520528,0,0,3
108,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.25197145318859426,1.781456953642384,2.4556305948351036,"['IFI27L2', 'PRKCH', 'PRKCD']",0.7435527872520528,0,0,3
109,Cytoplasmic Ribosomal Proteins WP477,0.2535170730375852,1.5040650406504066,2.0640647167255493,"['RPS26', 'RPS25', 'RPSA', 'RPL15', 'RPS4Y1']",0.7435527872520528,0,0,5
110,IL-18 signaling pathway WP4754,0.2541332983701308,1.3549107142857142,1.856087245989482,"['ADAMTS5', 'ARL4D', 'RGS16', 'PRKCD', 'FN1', 'TIMP3', 'CD36', 'ARF6']",0.7435527872520528,0,0,8
111,Wnt signaling pathway and pluripotency WP399,0.25560947015579316,1.5971275206731466,2.178648848369237,"['PRKCH', 'PRKCD', 'TCF7', 'LDLR']",0.7435527872520528,0,0,4
112,Calcium Regulation in the Cardiac Cell WP536,0.2624427221081893,1.4196763754045307,1.8991329197207698,"['GJD2', 'PRKCH', 'RGS16', 'CHRM5', 'PRKCD', 'ADRA1D']",0.7435527872520528,0,0,6
113,Insulin Signaling WP481,0.2678244677178876,1.365077951002227,1.7983857504965846,"['XBP1', 'RPS6KA5', 'PRKCH', 'SHC3', 'PRKCD', 'GAB1', 'ARF6']",0.7435527872520528,0,0,7
114,MAPK Signaling Pathway WP382,0.27280286931171965,1.2987172868432548,1.6870413337069738,"['DUSP4', 'RPS6KA5', 'TGFB1', 'GADD45A', 'DDIT3', 'PRKCD', 'FGF1', 'HSPA1B', 'DUSP7']",0.7435527872520528,0,0,9
115,Male infertility WP4673,0.27322205524093496,1.5461441213653604,2.0060762706579727,"['ABCB1', 'PEX10', 'TEX15', 'ETV5']",0.7435527872520528,0,0,4
116,Osteoblast differentiation WP4787,0.27322205524093496,1.5461441213653604,2.0060762706579727,"['PRKCH', 'PRKCD', 'FGF1', 'GLI3']",0.7435527872520528,0,0,4
117,Alpha 6 Beta 4 signaling pathway WP244,0.2749331095559161,2.0275330396475773,2.6180063143065015,"['PRKCD', 'GAB1']",0.7435527872520528,0,0,2
118,Serotonin and anxiety-related events WP3944,0.27604953778219926,3.473469387755102,4.470962766935231,['CRH'],0.7435527872520528,0,0,1
119,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.27604953778219926,3.473469387755102,4.470962766935231,['TGFB1'],0.7435527872520528,0,0,1
120,Trans-sulfuration pathway WP2333,0.27604953778219926,3.473469387755102,4.470962766935231,['AHCY'],0.7435527872520528,0,0,1
121,Galanin receptor pathway WP4970,0.27604953778219926,3.473469387755102,4.470962766935231,['PRKCD'],0.7435527872520528,0,0,1
122,Leptin and adiponectin WP3934,0.27604953778219926,3.473469387755102,4.470962766935231,['LEPR'],0.7435527872520528,0,0,1
123,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.27604953778219926,3.473469387755102,4.470962766935231,['TGFB1'],0.7435527872520528,0,0,1
124,Mitochondrial CII Assembly WP4920,0.27604953778219926,3.473469387755102,4.470962766935231,['SDHAF1'],0.7435527872520528,0,0,1
125,Glioblastoma signaling pathways WP2261,0.28210530045178617,1.5218473451327434,1.9258595741107556,"['PRKCH', 'CDKN2A', 'PRKCD', 'GAB1']",0.7537853628071727,0,0,4
126,BDNF-TrkB Signaling WP3676,0.2897847503698424,1.9462555066079295,2.410664907127847,"['TRPC3', 'GAB1']",0.7545996433494899,0,0,2
127,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.2897847503698424,1.9462555066079295,2.410664907127847,"['PRKCH', 'PRKCD']",0.7545996433494899,0,0,2
128,Proximal tubule transport WP4917,0.2897847503698424,1.9462555066079295,2.410664907127847,"['ABCB1', 'SLC3A1']",0.7545996433494899,0,0,2
129,GABA receptor Signaling WP4159,0.304598687800863,1.8712300914944087,2.224443757648394,"['SLC32A1', 'GAD1']",0.7545996433494899,0,0,2
130,"GPCRs, Other WP117",0.304598687800863,1.8712300914944087,2.224443757648394,"['ADRA1D', 'ACKR1']",0.7545996433494899,0,0,2
131,Alanine and aspartate metabolism WP106,0.3047108438757305,3.039010989010989,3.6115363622276,['GAD1'],0.7545996433494899,0,0,1
132,Hypertrophy Model WP516,0.3047108438757305,3.039010989010989,3.6115363622276,['WDR1'],0.7545996433494899,0,0,1
133,Purine metabolism WP4792,0.3047108438757305,3.039010989010989,3.6115363622276,['PRPS1'],0.7545996433494899,0,0,1
134,RAS and bradykinin pathways in COVID-19 WP4969,0.3047108438757305,3.039010989010989,3.6115363622276,['AGT'],0.7545996433494899,0,0,1
135,Pathways Regulating Hippo Signaling WP4540,0.3089922257957891,1.4533086778496895,1.7068226252147565,"['PRKCH', 'PRKD3', 'PRKCD', 'TCF7']",0.7545996433494899,0,0,4
136,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.3172100190021261,1.553191489361702,1.7833608061556796,"['ANGPT2', 'FN1', 'ANGPTL1']",0.7545996433494899,0,0,3
137,Hedgehog Signaling Pathway WP4249,0.31935469547925793,1.801762114537445,2.056626583260768,"['HHIP', 'GLI3']",0.7545996433494899,0,0,2
138,Canonical and non-canonical TGF-B signaling WP3874,0.3322398329829873,2.7010989010989013,2.9763359694945515,['TGFB1'],0.7545996433494899,0,0,1
139,Cysteine and methionine catabolism WP4504,0.3322398329829873,2.7010989010989013,2.9763359694945515,['AHCY'],0.7545996433494899,0,0,1
140,Fatty acid transporters WP5061,0.3322398329829873,2.7010989010989013,2.9763359694945515,['CD36'],0.7545996433494899,0,0,1
141,"GPCRs, Class B Secretin-like WP334",0.3322398329829873,2.7010989010989013,2.9763359694945515,['ADGRG2'],0.7545996433494899,0,0,1
142,Hedgehog Signaling Pathway Netpath WP47,0.3322398329829873,2.7010989010989013,2.9763359694945515,['GLI3'],0.7545996433494899,0,0,1
143,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.3322398329829873,2.7010989010989013,2.9763359694945515,['HMGCS1'],0.7545996433494899,0,0,1
144,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.3340341995143258,1.73725613593455,1.9049220220429581,"['IFITM3', 'DDIT3']",0.7545996433494899,0,0,2
145,Endoderm differentiation WP2853,0.3386237242495846,1.3229056203605514,1.4325291815151215,"['DUSP4', 'TGFB1', 'TCF7', 'SLC2A12', 'PBX3']",0.7545996433494899,0,0,5
146,Integrated Cancer Pathway WP1971,0.34862018007617007,1.677198845511165,1.767385615648806,"['BACH1', 'BBC3']",0.7545996433494899,0,0,2
147,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.34862018007617007,1.677198845511165,1.767385615648806,"['TGFB1', 'IFIT2']",0.7545996433494899,0,0,2
148,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.3500443368428122,1.4596026490066225,1.5321382679763884,"['SFRP4', 'TCF7', 'CXXC4']",0.7545996433494899,0,0,3
149,Nonalcoholic fatty liver disease WP4396,0.35280530954096506,1.2590804597701148,1.3117590078203263,"['XBP1', 'TGFB1', 'NDUFB11', 'DDIT3', 'LEPR', 'BBC3']",0.7545996433494899,0,0,6
150,Cell cycle WP179,0.3542582070570347,1.3517699115044248,1.4027711538147545,"['TGFB1', 'GADD45A', 'CDKN2A', 'GADD45G']",0.7545996433494899,0,0,4
151,NRF2 pathway WP2884,0.3542582070570347,1.3517699115044248,1.4027711538147545,"['TGFB1', 'SLC2A12', 'SLC39A7', 'CBR3']",0.7545996433494899,0,0,4
152,Serotonin and anxiety WP3947,0.35868114476430474,2.4307692307692306,2.492319859775363,['CRH'],0.7545996433494899,0,0,1
153,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.35868114476430474,2.4307692307692306,2.492319859775363,['CCK'],0.7545996433494899,0,0,1
154,Cori Cycle WP1946,0.35868114476430474,2.4307692307692306,2.492319859775363,['PGAM1'],0.7545996433494899,0,0,1
155,Leptin Insulin Overlap WP3935,0.35868114476430474,2.4307692307692306,2.492319859775363,['LEPR'],0.7545996433494899,0,0,1
156,Overview of nanoparticle effects WP3287,0.35868114476430474,2.4307692307692306,2.492319859775363,['FN1'],0.7545996433494899,0,0,1
157,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.35868114476430474,2.4307692307692306,2.492319859775363,['SFRP4'],0.7545996433494899,0,0,1
158,Melanoma WP4685,0.3609605139356716,1.4308531359563692,1.4580203242232748,"['CDKN2A', 'GADD45A', 'GADD45G']",0.7545996433494899,0,0,3
159,Nephrotic syndrome WP4758,0.3630970777318076,1.6211453744493391,1.6423581406282017,"['ANLN', 'GPC5']",0.7545996433494899,0,0,2
160,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.3718489131421907,1.4032093734080489,1.3881496458513791,"['HSPA5', 'UBE2L6', 'HSPA1B']",0.7545996433494899,0,0,3
161,One-carbon metabolism and related pathways WP3940,0.37745070519369844,1.568708256359244,1.5284164571139085,"['CHDH', 'GAD1']",0.7545996433494899,0,0,2
162,Prader-Willi and Angelman Syndrome WP3998,0.37745070519369844,1.568708256359244,1.5284164571139085,"['CDKN2A', 'NDN']",0.7545996433494899,0,0,2
163,Spinal Cord Injury WP2431,0.38270197664337074,1.3766087717106086,1.322230965329238,"['TGFB1', 'GADD45A', 'GFAP']",0.7545996433494899,0,0,3
164,Head and Neck Squamous Cell Carcinoma WP4674,0.38270197664337074,1.3766087717106086,1.322230965329238,"['CDKN2A', 'GAB1', 'FAT1']",0.7545996433494899,0,0,3
165,Airway smooth muscle cell contraction WP4962,0.3840776627826745,2.2095904095904095,2.11438026366655,['MYLK'],0.7545996433494899,0,0,1
166,Type II diabetes mellitus WP1584,0.3840776627826745,2.2095904095904095,2.11438026366655,['PRKCD'],0.7545996433494899,0,0,1
167,ERK Pathway in Huntington's Disease WP3853,0.3840776627826745,2.2095904095904095,2.11438026366655,['RPS6KA5'],0.7545996433494899,0,0,1
168,GDNF/RET signaling axis WP4830,0.3840776627826745,2.2095904095904095,2.11438026366655,['GLI3'],0.7545996433494899,0,0,1
169,Nanomaterial induced apoptosis WP2507,0.3840776627826745,2.2095904095904095,2.11438026366655,['ENDOG'],0.7545996433494899,0,0,1
170,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.3840776627826745,2.2095904095904095,2.11438026366655,['ABCB1'],0.7545996433494899,0,0,1
171,Genotoxicity pathway WP4286,0.3916681633076981,1.5195484581497798,1.4243340378172598,"['GADD45A', 'PCDH8']",0.7621741613439297,0,0,2
172,Non-small cell lung cancer WP4255,0.39351249558140655,1.3509933774834437,1.2599937825035634,"['CDKN2A', 'GADD45A', 'GADD45G']",0.7621741613439297,0,0,3
173,Ectoderm Differentiation WP2858,0.40192570700644814,1.2161862527716185,1.108539194484165,"['MAFB', 'NR2F2', 'JAKMIP1', 'PTPN13', 'GLI3']",0.7621741613439297,0,0,5
174,Globo Sphingolipid Metabolism WP1424,0.40847058347474074,2.025274725274725,1.813300112422103,['B3GALNT1'],0.7621741613439297,0,0,1
175,Kallmann's Syndrome WP5074,0.40847058347474074,2.025274725274725,1.813300112422103,['ASCL1'],0.7621741613439297,0,0,1
176,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.40847058347474074,2.025274725274725,1.813300112422103,['GADD45G'],0.7621741613439297,0,0,1
177,NAD+ metabolism WP3644,0.40847058347474074,2.025274725274725,1.813300112422103,['NMNAT1'],0.7621741613439297,0,0,1
178,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.40847058347474074,2.025274725274725,1.813300112422103,['ASCL1'],0.7621741613439297,0,0,1
179,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.40847058347474074,2.025274725274725,1.813300112422103,['BCL2L14'],0.7621741613439297,0,0,1
180,Circadian rhythm related genes WP3594,0.42393312262665367,1.158095238095238,0.99385366863565,"['PER2', 'AHCY', 'NFIL3', 'CRH', 'ATF5', 'HCRTR2']",0.7681610441503404,0,0,6
181,Vitamin B12 metabolism WP1533,0.431899482222878,1.8693153000845308,1.5694068356801403,['LDLR'],0.7681610441503404,0,0,1
182,miRNA regulation of p53 pathway in prostate cancer WP3982,0.431899482222878,1.8693153000845308,1.5694068356801403,['BBC3'],0.7681610441503404,0,0,1
183,Pregnane X receptor pathway WP2876,0.431899482222878,1.8693153000845308,1.5694068356801403,['ABCB1'],0.7681610441503404,0,0,1
184,Purinergic signaling WP4900,0.431899482222878,1.8693153000845308,1.5694068356801403,['P2RY14'],0.7681610441503404,0,0,1
185,Focal Adhesion WP306,0.4380869681105677,1.1397916666666668,0.9407131819420437,"['RELN', 'SHC3', 'COL5A2', 'FN1', 'MYLK', 'ACTG1']",0.7681610441503404,0,0,6
186,Regulation of Actin Cytoskeleton WP51,0.4490173888620635,1.1467179851901435,0.9181698251502647,"['CHRM5', 'FN1', 'FGF1', 'MYLK', 'ACTG1']",0.7681610441503404,0,0,5
187,Toll-like Receptor Signaling related to MyD88 WP3858,0.4544023772808483,1.7356357927786499,1.369021227777053,['TIRAP'],0.7681610441503404,0,0,1
188,Vitamin A and carotenoid metabolism WP716,0.4544023772808483,1.7356357927786499,1.369021227777053,['CD36'],0.7681610441503404,0,0,1
189,Constitutive Androstane Receptor Pathway WP2875,0.4544023772808483,1.7356357927786499,1.369021227777053,['ABCB1'],0.7681610441503404,0,0,1
190,Hematopoietic Stem Cell Differentiation WP2849,0.4544023772808483,1.7356357927786499,1.369021227777053,['RUNX1'],0.7681610441503404,0,0,1
191,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.4544023772808483,1.7356357927786499,1.369021227777053,['MYLK'],0.7681610441503404,0,0,1
192,Mitochondrial complex III assembly WP4921,0.4544023772808483,1.7356357927786499,1.369021227777053,['UQCC3'],0.7681610441503404,0,0,1
193,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.4571212480019406,1.2152317880794703,0.951291476831431,"['TGFB1', 'AGT', 'MYLK']",0.7681610441503404,0,0,3
194,VEGFA-VEGFR2 Signaling Pathway WP3888,0.4601946657448642,1.057249655715129,0.8205374763160024,"['TRPC3', 'TRAF3IP2', 'PRKCD', 'FN1', 'GAB1', 'APOLD1', 'RAB11A', 'HERPUD1', 'ACTG1', 'RPS6KA5', 'DNAJB9', 'IGFBP7', 'MYH11', 'ARF6']",0.7681610441503404,0,0,14
195,ATM Signaling Network in Development and Disease  WP3878,0.46034197175368985,1.31360876294797,1.0190788264862647,"['HMGN1', 'CDK5R1']",0.7681610441503404,0,0,2
196,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.46034197175368985,1.31360876294797,1.0190788264862647,"['TGFB1', 'TCF7']",0.7681610441503404,0,0,2
197,IL-4 signaling pathway WP395,0.46034197175368985,1.31360876294797,1.0190788264862647,"['HRH1', 'NFIL3']",0.7681610441503404,0,0,2
198,Small cell lung cancer WP4658,0.46746037715388905,1.1952013896428184,0.9088797677512654,"['GADD45A', 'FN1', 'GADD45G']",0.7681610441503404,0,0,3
199,Nucleotide Excision Repair WP4753,0.4735341926208864,1.2789241827034548,0.9560356733192978,"['RPA3', 'POLE2']",0.7681610441503404,0,0,2
200,Zinc homeostasis WP3529,0.4760157906385579,1.6197802197802198,1.2023697439470835,['SLC39A7'],0.7681610441503404,0,0,1
201,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.4760157906385579,1.6197802197802198,1.2023697439470835,['H2AFZ'],0.7681610441503404,0,0,1
202,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.4760157906385579,1.6197802197802198,1.2023697439470835,['FGF1'],0.7681610441503404,0,0,1
203,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.4760157906385579,1.6197802197802198,1.2023697439470835,['BBC3'],0.7681610441503404,0,0,1
204,Monoamine Transport WP727,0.4760157906385579,1.6197802197802198,1.2023697439470835,['AGT'],0.7681610441503404,0,0,1
205,Nucleotide metabolism WP404,0.4760157906385579,1.6197802197802198,1.2023697439470835,['PRPS1'],0.7681610441503404,0,0,1
206,Proteoglycan biosynthesis WP4784,0.4760157906385579,1.6197802197802198,1.2023697439470835,['PAPSS2'],0.7681610441503404,0,0,1
207,Nuclear Receptors Meta-Pathway WP2882,0.4864656752573821,1.0698407362272555,0.7709153959894692,"['ABCB1', 'TGFB1', 'B3GNT5', 'SLC2A12', 'SLC39A7', 'CBR3', 'FKBP5']",0.7681610441503404,0,0,7
208,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.4865298643478652,1.246018298881735,0.8977025969837492,"['RPS6KA5', 'PRKCD']",0.7681610441503404,0,0,2
209,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.4865298643478652,1.246018298881735,0.8977025969837492,"['ADCY10', 'TGFB1']",0.7681610441503404,0,0,2
210,p53 transcriptional gene network WP4963,0.4865298643478652,1.246018298881735,0.8977025969837492,"['GADD45A', 'BBC3']",0.7681610441503404,0,0,2
211,Corticotropin-releasing hormone signaling pathway WP2355,0.48786946198838915,1.1570482497634815,0.8304220966099115,"['TGFB1', 'PRKCD', 'CRH']",0.7681610441503404,0,0,3
212,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.4967748069954297,1.5184065934065933,1.0623052828448405,['RPS6KA5'],0.7681610441503404,0,0,1
213,TLR4 Signaling and Tolerance WP3851,0.4967748069954297,1.5184065934065933,1.0623052828448405,['TIRAP'],0.7681610441503404,0,0,1
214,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.4967748069954297,1.5184065934065933,1.0623052828448405,['TIRAP'],0.7681610441503404,0,0,1
215,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.4967748069954297,1.5184065934065933,1.0623052828448405,['ANGPT2'],0.7681610441503404,0,0,1
216,Purine metabolism and related disorders WP4224,0.4967748069954297,1.5184065934065933,1.0623052828448405,['PRPS1'],0.7681610441503404,0,0,1
217,Wnt signaling WP428,0.5078922382909088,1.1212429954151808,0.7596264132164923,"['SFRP4', 'TCF7', 'CXXC4']",0.7773972316618354,0,0,3
218,DNA IR-double strand breaks and cellular response via ATM WP3959,0.5119117956622995,1.1850220264317182,0.7934942362769956,"['CDKN2A', 'ACTL6A']",0.7773972316618354,0,0,2
219,1q21.1 copy number variation syndrome WP4905,0.5167131300267289,1.4289592760180996,0.9434952726040923,['FMO5'],0.7773972316618354,0,0,1
220,Trans-sulfuration and one-carbon metabolism WP2525,0.5167131300267289,1.4289592760180996,0.9434952726040923,['AHCY'],0.7773972316618354,0,0,1
221,Tryptophan metabolism WP465,0.5167131300267289,1.4289592760180996,0.9434952726040923,['ACMSD'],0.7773972316618354,0,0,1
222,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5167131300267289,1.4289592760180996,0.9434952726040923,['B3GALNT1'],0.7773972316618354,0,0,1
223,Glycerolipids and Glycerophospholipids WP4722,0.5358631367714499,1.3494505494505495,0.8418904754057306,['CDIPT'],0.7928141063040969,0,0,1
224,IL-7 signaling pathway WP205,0.5358631367714499,1.3494505494505495,0.8418904754057306,['IL7'],0.7928141063040969,0,0,1
225,PKC-gamma calcium signaling pathway in ataxia WP4760,0.5358631367714499,1.3494505494505495,0.8418904754057306,['TRPC3'],0.7928141063040969,0,0,1
226,AGE/RAGE pathway WP2324,0.5364550539662452,1.1296998258375166,0.7035459811846753,"['PRKCD', 'TIRAP']",0.7928141063040969,0,0,2
227,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.539691615516477,1.0289751587808635,0.6346280280879893,"['LINGO1', 'RPS6KA5', 'SHC3', 'PRKCD', 'CDK5R1']",0.7940836986013363,0,0,5
228,Acute viral myocarditis WP4298,0.5484047008434376,1.1039247096515818,0.6631736723280037,"['ENDOG', 'TGFB1']",0.7963790003552529,0,0,2
229,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5484047008434376,1.1039247096515818,0.6631736723280037,"['FN1', 'MYLK']",0.7963790003552529,0,0,2
230,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.5484047008434376,1.1039247096515818,0.6631736723280037,"['TGFB1', 'FAT1']",0.7963790003552529,0,0,2
231,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5542559295715709,1.2783111625216887,0.7543681456614493,['TGFB1'],0.797937415848727,0,0,1
232,Physiological and pathological hypertrophy of the heart WP1528,0.5542559295715709,1.2783111625216887,0.7543681456614493,['AGT'],0.797937415848727,0,0,1
233,Neural Crest Differentiation WP2064,0.5716498875629534,1.0557364489561387,0.5903979737543671,"['ASCL1', 'GFAP']",0.8128584810832057,0,0,2
234,Pathways affected in adenoid cystic carcinoma WP3651,0.5716498875629534,1.0557364489561387,0.5903979737543671,"['MYCBP', 'FOXP2']",0.8128584810832057,0,0,2
235,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5719213863908782,1.2142857142857142,0.6784866763044175,['RAB11A'],0.8128584810832057,0,0,1
236,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5783413229898985,0.9907892360484016,0.5425473283972704,"['DLX2', 'SST', 'TAC1', 'ASCL1']",0.8150461498225284,0,0,4
237,Aryl Hydrocarbon Receptor Pathway WP2873,0.5888882086273617,1.1563579277864993,0.612313391734578,['TGFB1'],0.8150461498225284,0,0,1
238,Ethanol effects on histone modifications WP3996,0.5888882086273617,1.1563579277864993,0.612313391734578,['AHCY'],0.8150461498225284,0,0,1
239,MTHFR deficiency WP4288,0.5888882086273617,1.1563579277864993,0.612313391734578,['CHDH'],0.8150461498225284,0,0,1
240,Oxysterols derived from cholesterol WP4545,0.5888882086273617,1.1563579277864993,0.612313391734578,['INSIG1'],0.8150461498225284,0,0,1
241,G Protein Signaling Pathways WP35,0.5925301569310064,0.9840701628781099,0.5150165733308352,"['PRKCH', 'PRKD3', 'PRKCD']",0.8150461498225284,0,0,3
242,Apoptosis WP254,0.594015030192137,1.0115638766519823,0.5268737093327134,"['CDKN2A', 'BBC3']",0.8150461498225284,0,0,2
243,Oxidative phosphorylation WP623,0.594015030192137,1.0115638766519823,0.5268737093327134,"['ATP6AP1', 'ATP6AP2']",0.8150461498225284,0,0,2
244,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.6048662216757039,0.9908298121010519,0.49813767327984526,"['TCF7', 'ACTG1']",0.8150461498225284,0,0,2
245,Sphingolipid pathway WP1422,0.6051839675328954,1.1036963036963037,0.5543014354176443,['SERINC1'],0.8150461498225284,0,0,1
246,IL17 signaling pathway WP2112,0.6051839675328954,1.1036963036963037,0.5543014354176443,['TRAF3IP2'],0.8150461498225284,0,0,1
247,Neovascularisation processes WP4331,0.6051839675328954,1.1036963036963037,0.5543014354176443,['TGFB1'],0.8150461498225284,0,0,1
248,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6051839675328954,1.1036963036963037,0.5543014354176443,['TGFB1'],0.8150461498225284,0,0,1
249,Signal transduction through IL1R WP4496,0.6208351487649745,1.0556139512661251,0.5032002905831711,['TGFB1'],0.822852935267863,0,0,1
250,The influence of laminopathies on Wnt signaling WP4844,0.6208351487649745,1.0556139512661251,0.5032002905831711,['TCF7'],0.822852935267863,0,0,1
251,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.6208351487649745,1.0556139512661251,0.5032002905831711,['ANGPT2'],0.822852935267863,0,0,1
252,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.6208351487649745,1.0556139512661251,0.5032002905831711,['AGT'],0.822852935267863,0,0,1
253,Glycerophospholipid Biosynthetic Pathway WP2533,0.6358671944899813,1.0115384615384615,0.4579897690394159,['CDIPT'],0.8296079803111475,0,0,1
254,Melatonin metabolism and effects WP3298,0.6358671944899813,1.0115384615384615,0.4579897690394159,['PER2'],0.8296079803111475,0,0,1
255,Nuclear receptors WP170,0.6358671944899813,1.0115384615384615,0.4579897690394159,['NR2F2'],0.8296079803111475,0,0,1
256,Oxidative Damage WP3941,0.6358671944899813,1.0115384615384615,0.4579897690394159,['GADD45A'],0.8296079803111475,0,0,1
257,Base Excision Repair WP4752,0.6503045451130881,0.970989010989011,0.41783064579348694,['POLE2'],0.8386166720763376,0,0,1
258,Complement system WP2806,0.6503045451130881,0.970989010989011,0.41783064579348694,['DCN'],0.8386166720763376,0,0,1
259,Nanoparticle-mediated activation of receptor signaling WP2643,0.6503045451130881,0.970989010989011,0.41783064579348694,['FN1'],0.8386166720763376,0,0,1
260,Glycolysis and Gluconeogenesis WP534,0.664170678043593,0.9335587489433643,0.38202728650452433,['PGAM1'],0.8440777382912195,0,0,1
261,miRNA regulation of prostate cancer signaling pathways WP3981,0.664170678043593,0.9335587489433643,0.38202728650452433,['TCF7'],0.8440777382912195,0,0,1
262,Prion disease pathway WP3995,0.664170678043593,0.9335587489433643,0.38202728650452433,['HSPA5'],0.8440777382912195,0,0,1
263,Thermogenesis WP4321,0.6671752182900657,0.8766456554695604,0.3547807510435776,"['ADCY10', 'ACTL6A', 'ACTG1']",0.8440777382912195,0,0,3
264,Gastrin signaling pathway WP4659,0.6671752182900657,0.8766456554695604,0.3547807510435776,"['PRKCH', 'CDKN2A', 'PRKCD']",0.8440777382912195,0,0,3
265,T-cell receptor (TCR) signaling pathway WP69,0.6746856130732325,0.8664254247954688,0.34094573030024844,"['TGFB1', 'PRKCD']",0.8474945346531748,0,0,2
266,ATM Signaling Pathway WP2516,0.6774881459652625,0.8989010989010989,0.34999902912668246,['GADD45A'],0.8474945346531748,0,0,1
267,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6774881459652625,0.8989010989010989,0.34999902912668246,['SUPT4H1'],0.8474945346531748,0,0,1
268,Type 2 papillary renal cell carcinoma WP4241,0.6902786130483411,0.8667189952904238,0.32125804187547335,['TGFB1'],0.8539002102153552,0,0,1
269,Hepatitis C and Hepatocellular Carcinoma WP3646,0.6902786130483411,0.8667189952904238,0.32125804187547335,['TGFB1'],0.8539002102153552,0,0,1
270,IL-5 signaling pathway WP127,0.6902786130483411,0.8667189952904238,0.32125804187547335,['SPRED1'],0.8539002102153552,0,0,1
271,Parkinson's disease pathway WP2371,0.7025628896728933,0.8367563471011746,0.2953920261455049,['UBE2L6'],0.8644802999934231,0,0,1
272,Signaling of Hepatocyte Growth Factor Receptor WP313,0.714360966461631,0.8087912087912088,0.2720505828520775,['GAB1'],0.8644802999934231,0,0,1
273,Target Of Rapamycin (TOR) Signaling WP1471,0.714360966461631,0.8087912087912088,0.2720505828520775,['RRAGA'],0.8644802999934231,0,0,1
274,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.714360966461631,0.8087912087912088,0.2720505828520775,['IGFBP5'],0.8644802999934231,0,0,1
275,Fas ligand pathway and stress induction of heat shock proteins WP314,0.714360966461631,0.8087912087912088,0.2720505828520775,['ACTG1'],0.8644802999934231,0,0,1
276,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.714360966461631,0.8087912087912088,0.2720505828520775,['ACTG1'],0.8644802999934231,0,0,1
277,Aryl Hydrocarbon Receptor Netpath WP2586,0.7256920459093421,0.7826302729528536,0.25093437919072925,['CD36'],0.8718746163083463,0,0,1
278,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7256920459093421,0.7826302729528536,0.25093437919072925,['CDKN2A'],0.8718746163083463,0,0,1
279,TGF-beta Receptor Signaling WP560,0.7365745739933682,0.7581043956043956,0.23178647198547955,['TGFB1'],0.8786282418349464,0,0,1
280,IL-3 signaling pathway WP286,0.7365745739933682,0.7581043956043956,0.23178647198547955,['TGFB1'],0.8786282418349464,0,0,1
281,B Cell Receptor Signaling Pathway WP23,0.7418472608476071,0.7575715859030837,0.22621989437874176,"['PRKCD', 'GAB1']",0.8796699507085308,0,0,2
282,Cytosolic DNA-sensing pathway WP4655,0.7470262694846685,0.7350649350649351,0.2143853105804859,['POLR1C'],0.8796699507085308,0,0,1
283,Pyrimidine metabolism WP4022,0.7493523651766343,0.7458488647915961,0.2152116756558996,"['POLE2', 'POLR1C']",0.8796699507085308,0,0,2
284,Chemokine signaling pathway WP3929,0.7504523398737868,0.765074939003137,0.2196370512583124,"['SHC3', 'PRKCD', 'CXCL14']",0.8796699507085308,0,0,3
285,Interleukin-11 Signaling Pathway WP2332,0.757064152738844,0.7133807369101487,0.19853905471474073,['TGFB1'],0.8796699507085308,0,0,1
286,PI3K-Akt signaling pathway WP4172,0.7593988944236086,0.7976556776556777,0.2195372462782714,"['RELN', 'ANGPT2', 'IL7', 'FN1', 'COL6A6', 'FGF1']",0.8796699507085308,0,0,6
287,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7638012538122585,0.7234532184890525,0.1949327787561966,"['SHC3', 'GAB1']",0.8796699507085308,0,0,2
288,Metabolic reprogramming in colon cancer WP4290,0.7667045731622859,0.6929356357927786,0.1840809319328671,['PGAM1'],0.8796699507085308,0,0,1
289,Pathogenic Escherichia coli infection WP2272,0.7667045731622859,0.6929356357927786,0.1840809319328671,['ACTG1'],0.8796699507085308,0,0,1
290,Hepatitis B infection WP4666,0.7742155869617293,0.7338952438290187,0.18780739489049264,"['TGFB1', 'ATP6AP1', 'TIRAP']",0.8796699507085308,0,0,3
291,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7759632355340564,0.6736263736263737,0.17086542182938363,['TGFB1'],0.8796699507085308,0,0,1
292,Common Pathways Underlying Drug Addiction WP2636,0.7759632355340564,0.6736263736263737,0.17086542182938363,['ACTG1'],0.8796699507085308,0,0,1
293,PPAR signaling pathway WP3942,0.7759632355340564,0.6736263736263737,0.17086542182938363,['CD36'],0.8796699507085308,0,0,1
294,EGF/EGFR signaling pathway WP437,0.7821435048713797,0.7447243022464262,0.182991455041863,"['RPS6KA5', 'PRKCD', 'GAB1', 'ARF6']",0.8796699507085308,0,0,4
295,ESC Pluripotency Pathways WP3931,0.7841185003073748,0.6922592825676526,0.1683540804735504,"['GAB1', 'FGF1']",0.8796699507085308,0,0,2
296,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7848552254824616,0.6553608553608553,0.15876510222404644,['HSPA5'],0.8796699507085308,0,0,1
297,Glucocorticoid Receptor Pathway WP2880,0.7848552254824616,0.6553608553608553,0.15876510222404644,['B3GNT5'],0.8796699507085308,0,0,1
298,RANKL/RANK signaling pathway WP2018,0.7848552254824616,0.6553608553608553,0.15876510222404644,['PAPSS2'],0.8796699507085308,0,0,1
299,Regulation of Microtubule Cytoskeleton WP2038,0.801596579359757,0.6216398985629755,0.1374755491397165,['SPRED1'],0.8952452310139144,0,0,1
300,ErbB signaling pathway WP673,0.8088124800665011,0.6546017383021788,0.13889875215965192,"['SHC3', 'GAB1']",0.8952452310139144,0,0,2
301,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8094732328329405,0.606043956043956,0.12810046411900847,['RPS6KA5'],0.8952452310139144,0,0,1
302,Modulators of TCR signaling and T cell activation WP5072,0.8094732328329405,0.606043956043956,0.12810046411900847,['ZFP36L1'],0.8952452310139144,0,0,1
303,Ciliopathies WP4803,0.8228598069387744,0.6959317501750811,0.13568542135054748,"['MAK', 'CCDC65', 'CCDC28B', 'GLI3']",0.9070467838863058,0,0,4
304,Fragile X Syndrome  WP4549,0.8301182918686848,0.6598434677904876,0.12285432062192973,"['CDKN2A', 'GAD1', 'GAB1']",0.9073445707347052,0,0,3
305,Cardiac Hypertrophic Response WP2795,0.8312797564216162,0.5636084845387171,0.10414858650828022,['TGFB1'],0.9073445707347052,0,0,1
306,Interferon type I signaling pathways WP585,0.8312797564216162,0.5636084845387171,0.10414858650828022,['RPS6KA5'],0.9073445707347052,0,0,1
307,Integrated breast cancer pathway WP1984,0.8431432179127201,0.6421496805954404,0.10956257973418755,"['GADD45A', 'JAKMIP1', 'BACH1']",0.9156971133765559,0,0,3
308,Synaptic Vesicle Pathway WP2267,0.8444153021556263,0.5384615384615384,0.09105968374710198,['SLC32A1'],0.9156971133765559,0,0,1
309,3q29 copy number variation syndrome WP4906,0.8565302479119704,0.5154547580079495,0.07982623414665689,['TGFB1'],0.9258288116588936,0,0,1
310,Mitochondrial complex I assembly model OXPHOS system WP4324,0.8622299711238098,0.5046703296703297,0.07480892620054853,['NDUFB11'],0.9281309885226611,0,0,1
311,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8642177767381665,0.5693184762891941,0.08308092166553906,"['TGFB1', 'FN1']",0.9281309885226611,0,0,2
312,Toll-like Receptor Signaling Pathway WP75,0.8677037308758073,0.4943260820811841,0.07014731621242025,['TIRAP'],0.9288879683093578,0,0,1
313,AMP-activated protein kinase (AMPK) signaling WP1403,0.8729604665816162,0.4843956043956044,0.06581241301758564,['LEPR'],0.9291166516048802,0,0,1
314,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8734809239638694,0.6559095729297214,0.08872422432568206,"['RELN', 'ANGPT2', 'COL5A2', 'FN1', 'FGF1']",0.9291166516048802,0,0,5
315,Mesodermal commitment pathway WP2857,0.8804212208140645,0.5435331386427759,0.0692215683052729,"['SLC2A12', 'PBX3']",0.9335259928631668,0,0,2
316,MET in type 1 papillary renal cell carcinoma WP4205,0.8875127113359765,0.45685258138088325,0.05451733101929415,['GAB1'],0.9380672328677727,0,0,1
317,Ras signaling WP4223,0.9044649099636762,0.5530054092310803,0.0555282518796217,"['SHC3', 'GAB1', 'ARF6']",0.9500617928800085,0,0,3
318,TGF-beta Signaling Pathway WP366,0.9045498507061158,0.503579295154185,0.05051799801705225,"['TGFB1', 'FN1']",0.9500617928800085,0,0,2
319,Alzheimer's disease WP2059,0.9081639211279838,0.4172792724516862,0.04019667371796166,['CDK5R1'],0.9504239647271041,0,0,1
320,16p11.2 proximal deletion syndrome WP4949,0.9118158251178076,0.4101694915254237,0.03786572172466389,['CDIPT'],0.9504239647271041,0,0,1
321,DNA Repair Pathways Full Network WP4946,0.9134314152017977,0.4881858229875851,0.04420375445318562,"['RPA3', 'POLE2']",0.9504239647271041,0,0,2
322,DNA IR-damage and cellular response via ATR WP4016,0.9186906191993289,0.3966492523869573,0.03363818204109356,['ABRAXAS1'],0.9529275366850183,0,0,1
323,Leptin signaling pathway WP2034,0.9280130061493232,0.3779532967032967,0.028236713554383633,['LEPR'],0.9537206899051376,0,0,1
324,Pathways in clear cell renal cell carcinoma WP4018,0.9280130061493232,0.3779532967032967,0.028236713554383633,['TGFB1'],0.9537206899051376,0,0,1
325,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9289195143666469,0.460037759597231,0.033920047289945576,"['RPS6KA5', 'SHC3']",0.9537206899051376,0,0,2
326,Joubert Syndrome WP4656,0.9308770805660923,0.3721048182586644,0.026653138765071485,['PDE6B'],0.9537206899051376,0,0,1
327,Regulation of toll-like receptor signaling pathway WP1449,0.9412404091360176,0.35040611562350693,0.021219434313585903,['TIRAP'],0.9601993751695498,0,0,1
328,22q11.2 copy number variation syndrome WP4657,0.9458251330262931,0.3404736108961461,0.018963554759749382,['RELN'],0.9601993751695498,0,0,1
329,Metapathway biotransformation Phase I and II WP702,0.9458251330262931,0.3404736108961461,0.018963554759749382,['FMO5'],0.9601993751695498,0,0,1
330,Integrin-mediated Cell Adhesion WP185,0.9500528415487177,0.3310853530031612,0.016964043135557955,['SHC3'],0.9615686335674901,0,0,1
331,Androgen receptor signaling pathway WP138,0.9557850987437381,0.31792943898207054,0.014377463369079484,['ETV5'],0.9633143886412536,0,0,1
332,7q11.23 copy number variation syndrome WP4932,0.9575460390086712,0.3137719423433709,0.013611890164364262,['UBE2L6'],0.9633143886412536,0,0,1
333,Genes related to primary cilium development (based on CRISPR) WP4536,0.9778535444989372,0.25941155618574974,0.005809617825095191,['CDK20'],0.9807900416295647,0,0,1
334,Ciliary landscape WP4352,0.9995023020505954,0.12860687699397377,6.402331241677319e-05,['DOCK5'],0.9995023020505954,0,0,1
